Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$3.64 - $7.76 $1.11 Million - $2.36 Million
-304,654 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$4.78 - $8.26 $420,138 - $726,012
87,895 Added 40.55%
304,654 $2.11 Million
Q1 2020

May 13, 2020

BUY
$4.0 - $21.53 $240,000 - $1.29 Million
60,000 Added 38.28%
216,759 $867,000
Q4 2019

Feb 13, 2020

BUY
$13.94 - $24.12 $2.19 Million - $3.78 Million
156,759 New
156,759 $3.36 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.